Funding excellent research
Aiming for a life without EB
EB Resnet supports and coordinates research funding on behalf of its member patient organisations and partners. We currently offer three funding schemes: Research grants through scheduled Calls for proposals, Ad-hoc grants our flexible funding scheme, and Co-funding for industry-partnering projects.
EB Resnet welcomes proposals for innovative research and clinical development of treatments or diagnostics. All proposals are evaluated for scientific excellence, feasibility and value for money, and whether they address the priority needs of people with EB. We undertake peer review to ensure that only the best research is funded.
Our funding schemes. How do your ideas fit in?
Research grants | Ad-hoc grants | Industry co-funding |
---|---|---|
Upcoming Research Grant Call | Open until 31st March 2024 | Open |
|
|
|
Upcoming Call 2024, and Special Call 2023
Submissions for the AP Call 2024 are expected to be possible from mid-June and the Expert Meeting is planned for December 2024. Evaluation of proposal submitted to the Special Call 2023 focusing on chronic inflammation and fibrosis (CIF), cancer initiation & repurposing, which EB Resnet member DEBRA Austria is jointly funding with LifeArc, is still ongoing.
The AP Call and the Special Ad-hoc Call from 2022 have both been completed. Results of the funded projects can be found in the overview tables 2022.